本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cytokinetics

79.20
+1.742.25%
盘后79.250.0500+0.06%19:30 EDT
成交量:123.66万
成交额:9,726.71万
市值:110.11亿
市盈率:-11.03
高:79.88
开:77.91
低:76.70
收:77.46
52周最高:88.31
52周最低:35.22
股本:1.39亿
流通股本:1.38亿
量比:0.86
换手率:0.90%
股息:- -
股息率:- -
每股收益(TTM):-7.1827
每股收益(LYR):-6.5400
净资产收益率:-572.15%
总资产收益率:-28.09%
市净率:-63.47
市盈率(LYR):-12.11

数据加载中...

2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/07/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/27

重要事件披露

Form 8-K - Current report
2026/05/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

重要事件披露

Form 8-K - Current report